申请人:Isis Pharmaceuticals, Inc.
公开号:US06087482A1
公开(公告)日:2000-07-11
Oligonucleotide-mimicking macromolecules that have improved nuclease resistance are provided. Replacement of the normal phosphorodiester inter-sugar linkages found in natural oligonucleotides with four atom linking groups provide unique compounds that are useful in regulating RNA expression and in therapeutics. Methods of synthesis and use also are disclosed.
提供了具有改善核酸酶抵抗力的寡核苷酸模拟大分子。用四原子连接基替换天然寡核苷酸中的正常磷酸二酯间糖连接,提供了独特的化合物,可用于调节RNA表达和治疗。还公开了合成和使用的方法。